Complement: A critical test of its biological importance

Immunological Reviews

Volumn 178, Issue , 2000, Pages 166-176

  Schmidt, Bela Z ^a,b   Colten, Harvey R ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Imetrikusinc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C5A;

AUTOIMMUNITY; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT SYSTEM; GRAFT REJECTION; HOST RESISTANCE; HUMAN; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE INJURY; XENOTRANSPLANTATION;

EID: 0034501076     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2000.17801.x     Document Type: Review

References (140)

1. Immunoproteins
2. Genetic deficiencies of complement
3. Complement and complement deficiencies
4. Complement deficiencies
5. Genetically controlled total deficiency of the fourth component of complement in guinea pig
6. Linkage of total deficiency of the second component (C2) of the complement system and of genetic C2-polymorphism to the major histocompatibility complex of the guinea pig
7. An inherited deficiency of the third component of complement, C3, in guinea pigs
8. Genetically determined deficiency of the third component of complement in the dog
9. Deficiency of the sixth component of complement in rabbits with an inherited complement defect
10. Extensive complement activation in hereditary porcine membranoproliferative glomerulonephritis type II (porcine dense deposit disease)
11. Genetic deficiency of the fourth component of complement (C4) in Wistar rats
12. Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts
13. An α-globulin allotype in the mouse (MuB1)
14. The inheritance of hemolytic complement activity in CF-1 mice
15. The primary structure of rabbit β-globin mRNA as determined from clone DNA
16. Human β-globin messenger RNA III. Nucleotide sequences derived from complementary DNA
17. Sequence of chicken ovalbumin mRNA
18. Nucleotide sequence of a cDNA done encoding human preproinsulin
19. Immunoglobulin light-chain structural sequences cloned in a bacterial plasmid
20. Mouse complement components C3 and C4. Characterization of their messenger RNA and molecular cloning of complementary DNA for C3
21. Isolation of cDNA clones for the human complement protein factor B, a class III major histocompatibility complex gene product
22. Cloning of a human complement component C4 gene
23. Genetics and biosynthesis of complement proteins
24. Type II human complement C2 deficiency. Allele specific amino acid substitutions (Ser 189-Phe, Gly444-Arg) cause impaired C2 secretion
25. Human factor H deficiency Mutations in framework cysteine residues and block in H protein secretion and intracellular catabolism
26. Dysfunctional C1 -inhibitor (At), isolated from type II hereditary angioedema plasma, contains a P1 "reactive centre" (Arg444-His) mutation
27. Molecular analysis of the third component of canine complement (C3) and identification of the mutation responsible for hereditary canine C3 deficiency
28. Type I human complement C2 deficiency. A 28-base pair gene deletion causes skipping of exon 6 during RNA splicing
29. Molecular heterogeneity in deficiency of complement protein C2 type I
30. Polymorphism of the human complement C4 and steroid 21-hydroxylase genes
31. Molecular genetics of the human MHC complement gene cluster
32. Null alleles of human complement C4. Evidence for pseudogenes at the C4A locus and gene conversion at the C4B locus
33. Deficiency of human complement protein C4 due to identical frameshift mutations in the C4A and C4B genes
34. Transinhibition of C1 inhibitor synthesis in type I hereditary angioneurotic edema
35. Deficiency of the first component of the human complement
36. Reduced C8 messenger RNA expression in families with hereditary C8 deficiency
37. Role of the collagen-like domain of the human mannan-binding protein in the activation of complement and the secretion of this lectin
38. Disruption of disulfide bonds is responsible for impaired secretion in human complement factor H deficiency
39. Soluble human complement receptor type I: In vivo inhibitor of complement suppressung post-ischemic mycardial inflammation and necrosis
40. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats
41. Proceedings: Complement activation following myocardial infarction
42. Redution by cobra venom factor of myocardial necrosis after coronary artery occlusion
43. Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury
44. Complement deposition in early cardiac transplant biopsies is associated with ischemis injury and subsequent rejection episodes
45. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement
46. Intestinal reperfusion injury is mediated by IgM and complement
47. Myocardial ischemia-reperfusion injury in CD18- and ICAM-1-deficient mice
48. Experimental murine acid aspiration injury is mediated by neutrophils and the alternative complement pathway
49. Activated complement component 3 (C3) is required for ultraviolet induction of immunosuppression and antigenic tolerance
50. Neutrophil-dependent oxygen-radical-mediated lung injury associated with acute pancreatitis
51. Complement component C5 deficiency reduces edema formation in murine ligation-induced acute pancreatitis
52. Hereditary absence of complement C5 in adult mice influences Wallerian degeneration, but not retrograde responses, following injury to peripheral nerve
53. Hereditary deficiencies in complement C5 are associated with intensified neurodegenerative responses that implicate new roles for the C-system in neuronal and astrocytic functions
54. Expression of C5a receptor in mouse brain: Role in signal transduction and neurogeneration
55. The role of complement activation in tumour necrosis factor-induced lethal hepatitis
56. The role of complement in the passive cutaneous reaction of mice
57. Impaired inflammatory responses in the reverse Arthus reaction through genetic deletion of the C5a receptor
58. Neurogenic amplification of immune complex inflammation
59. Impaired IgG-dependent anaphylaxis and Arthus reaction in FcγRIII (CD 16) deficient mice
60. Fc receptors initiate the Arthus reaction: Redefining the inflammatory cascade
61. Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury
62. Capsaicin-induced desensitization of airway mucosa to cigarette smoke, mechanical and chemical irritants
63. Reduction of myocardial infarct size with sCR1sLe(x), an alternatively glycosylated form of human soluble complement receptor type 1 (sCR1), possessing sialyl Lewis x
64. x-glycosylated complement inhibitory protein
65. Cardiac xenotransplantation into complement S-deficient mice
66. Expression of human CD59 in transgenic pig organs enhances organ survival in an ex vivo xenogenic perfusion model
67. Transenic expression of a CD46 (membrane cofactor protein) minigene: Studies of xenotransplantation and measles virus infection
68. The role of CD11b/CD18 mediated neutrophil adhesion in complement deficient xenograft recipients
69. Uber die specifische bedeutung der choleraimmunitat
70. An analysis of the opsonic and tropic action of normal and immune sera based on experiments with Pneumococcus
71. Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA
72. Studies of group B sreptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role For complement in both innate and acquired immunity
73. The time-dependent clearance of virulent Treponemo pallidum in susceptible and resistant strains of guinea pigs is significantly different
74. Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae
75. Opsonic activity in the newborn: Role of properdin
76. Activity of the alternative pathway of complement in the newborn infant
77. Alternative pathway of complement activation in full term and premature infants
78. Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement
79. Abrogation of the alternative complement pathway by targeted deletion of murine factor B
80. The C5a chemoattractant receptor mediates mucosal defence to infection
81. The pulmonary response of C5 sufficient and deficient mice to Pseudomonas aeruginosa
82. Lung defenses against Pseudomonas aeruginosa in in C5-deficient mice with different genetic backgrounds
83. Impaired mast cell-dependent natural immunity in complement C3-deficient mice
84. Role of complement receptors in uptake of Mycobacterium avium by macrophages in vivo: Evidence from studies using CD18-deficient mice
85. Sporozoites of Plasmodium yoelii infect mice with targeted deletions in ICAM-1 and ICAM-2 or complement components C3 and C4
86. Early inflammatory responses to Candida albicans infection in inbred and complement-deficient mice
87. Strain-dependent differences in host response to Candida albicans infection in mice are related to organ susceptibility and infectious load
88. Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo
89. Humoral response to herpes simplex virus is complement dependent
90. Depletion of plasma complement in vivo by a protein of cobra venom: Its effect on various immunologic reactions
91. Role of complement in induction of antibody production in vivo
92. The role of complement in the induction of antibody responses
93. Influence of genetically inherited complement deficiencies on humoral response in guinea pigs
94. Impaired humoral immune response in complement C3-deficient guinea pigs: Absence of secondary antibody response
95. Role of C3 in humoral immunity. Defective antibody production in C3-deficient dogs
96. Immune response of a patient with deficiency of the fourth component of complement and systemic lupus erythematosus
97. In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody
98. Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo
99. Suppression of the immune response by a soluble complement receptor of B lymphocytes
100. Growth control of activated, synchronized murine B cells by the C3d fragment of human complement
101. The action of human C3 in soluble or cross-linked form with resting and activated murine B lymphocytes
102. The role of C3 in the immune response
103. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2
104. Antibody response to a T-dependent antigen requires B cell expression of complement receptors
105. Dependence of germinal center B cells on expression of CD21/CD35 for survival
106. Modulation of the humoral immune response by antibody-mediated antigen targeting to complement receptors and Fc receptors
107. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response
108. Regulation of the B cell response to T-dependent antigens by classical pathway complement
109. Local synthesis of C3 within the splenic lymphoid compartment can reconstitute the impaired immune response in C3-deficient mice
110. T-cell-dependent immune response in C1 q-deficient mice: Defective interferon γ production in antigen-specific T cells
111. Role of antibody and complement in the immune clearance and destruction of erythrocytes
112. Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice
113. Overexpression of Crry protects mesangial cells from complement-mediated injury
114. Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble routine complement inhibitor
115. Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury
116. Renal, central nervous system and pancreatic overexpression of recombinant soluble Crry in transgenic mice. A novel means of protection from complement-mediated injury
117. Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3- and C4-deficient mice
118. Acute nephrotoxic serum nephritis in complement knockout mice: Relative roles of the classical and the alternate pathways in neutrophil recruitment and proteinuria
119. Anti-GBM nephritis in the mouse: Role of granulocytes in the heterologous phase
120. Immunopathogenesis of glomerular capillary wall injury in nephrotic states
121. Immune complex glomerulonephritis in C4- and C3-deficient mice
122. Modulation of renal disease in MRL/1pr mice genetically deficient in complement factor B
123. A critical role for complement in maintenance of self-tolerance
124. Role of complement receptors CD21/CD35 in B lymphocyte activation and survival
125. Deficiencies of the first component of complement (C1): An update
126. C1q and systemic lupus erythematosus
127. Hereditary C2 deficiency with some manifestations of systemic lupus erythematosus
128. Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: Importance of null alleles of C4A and C4B in determining disease susceptibility
129. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
130. Complement-dependent clearance of apoptotic cells by human macrophages
131. C1q binds directly and specifically to surface blebs of apoptotic human kerationocytes. Complement deficiency and systemic lupus erythematosus revisited
132. A targeted disruption of the murine complement factor B gene resulting in loss of expression of three genes in dose proximity, factor B, C2 and D 17H6S45
133. C1q protects against the development of glomerulonephritis independently of C3 activation
134. Systemic lupus erythematosus and complement deficiency: Clues to a novel role for the classical complement pathway in the maintenance of immune tolerance
135. Cloning of the mouse homolog of the 126-kDa human Clq/MBL/SP-A receptor, C1qR(p)
136. A critical role for routine complement regulator Crry in fetomaternal tolerance
137. Estrogen regulation of tissue-specific expression of complement C3
138. In vitro complement activation by ragweed allergen extract in the sera of ragweed allergic and non-allergic persons
139. Genetic deficiency of acylation stimulating protein (ASP(C3ades-Arg)) does not cause hyperapobetalipoproteinemia in mice
140. Mice lacking acylation stimulating protein (ASP) have delayed postprandial triglyceride clearance